Hemoglobinuria, Paroxysmal
Information
- Disease name
- Hemoglobinuria, Paroxysmal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00438789 | Approved for marketing | The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol | |||
NCT00122304 | Completed | Phase 3 | Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab | December 2004 | November 2006 |
NCT00122330 | Completed | Phase 3 | Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients | October 2004 | January 2006 |
NCT00152139 | Completed | Phase 3 | Stem Cell Transplantation for Patients With Hematologic Malignancies | May 2002 | January 2009 |
NCT00098280 | Completed | Phase 3 | Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria | December 2004 | February 2006 |
NCT00721864 | Completed | The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) | May 2006 | December 2010 | |
NCT00867932 | Completed | Phase 4 | Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) | October 2, 2009 | May 12, 2011 |
NCT00975975 | Completed | Phase 2 | Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer | September 2009 | November 2013 |
NCT00997386 | Completed | Phase 2 | Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States | September 2009 | January 2016 |
NCT00618969 | Completed | Phase 2 | Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors | February 2008 | February 2016 |
NCT00315419 | Unknown status | Identifying Characteristics of Bone Marrow Failure Syndromes | April 2006 | July 2009 | |
NCT01642979 | Unknown status | Phase 2 | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria | July 2012 | July 2017 |
NCT01760096 | Unknown status | Phase 2 | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) | January 2013 | July 2017 |
NCT01224483 | Unknown status | Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients | August 2010 | December 2010 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006457